# OnCo record spotlight-glow (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/spotlight-glow/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "spotlight-glow", "NCT03504397" ;
  schema:name "SPOTLIGHT & GLOW"@en ;
  schema:alternateName "SPOTLIGHT"@en, "GLOW"@en, "spotlight-glow"@en ;
  schema:description "Two trials that made Claudin 18.2 the third biomarker in stomach cancer, adding about two to three months of survival with an antibody against it."@en ;
  schema:url <https://onco.cc/trials/spotlight-glow/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03504397>, <https://clinicaltrials.gov/study/NCT03653507> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-06-21" ;
  onco:cancers <https://onco.cc/cancers/gastric/>, <https://onco.cc/cancers/gastric-cldn18-2-positive/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cldn18-2/> ;
  onco:drugs <https://onco.cc/drugs/zolbetuximab/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/capox/>, <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/capecitabine/> ;
  onco:companies <https://onco.cc/companies/astellas/> ;
  onco:people <https://onco.cc/people/ryu-min-hee/>, <https://onco.cc/people/shitara-kohei/>, <https://onco.cc/people/rha-sun-young/>, <https://onco.cc/people/kang-yoon-koo/> .